Pablo Okhuysen is an Infectious Disease physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 233 publications with 13,997 citations (h-index 54); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1515 Holcombe Blvd
Houston, TX 770304009
Telephone
713-792-6161Registry record last updated 14 Mar 2014.
Clinical trials
- Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy
Sponsor: Napo Pharmaceuticals, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Napo Pharmaceuticals IncProgram year20259 payments
- Napo Pharmaceuticals IncProgram year20242 payments$13,454openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 1997–2023 per NIH RePORTER. The latest:
- Mucosal determinants of Cryptosporidium infection
Baylor College of Medicine
FY2023$557,142U19AI144297 - Mucosal determinants of Cryptosporidium infection
Baylor College of Medicine
FY2022$557,143U19AI144297 - Mucosal determinants of Cryptosporidium infection
Baylor College of Medicine
FY2021$440,083U19AI144297
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment
Science Translational Medicine
2022 - Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer
International Journal of Radiation Oncology*Biology*Physics
2020 - Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Journal for ImmunoTherapy of Cancer
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”